TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2014

Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy.

Nicholas T Funderburg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.